Picture of CellaVision AB logo

CEVI — CellaVision AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: CellaVision Q4 EBITDA SEK 48 Million

Feb 7 (Reuters) - CellaVision Q4 EBITDA margin 32%.
* Q4 EBITDA SEK 48 million
* Q4 adjusted EPS SEK 1.35
* Q4 pretax profit SEK 40 million
* Q4 sales SEK 152 million

Recent news on CellaVision AB

See all news